Stocks
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -16.1 | -6.71 | -10.9 | -5.21 | -4.16 | -5.16 | |
| Changes by years, y/y, % | -113% | -58% | +63% | -52% | -20% | |||
Denali Therapeutics. EV/EBITDA
Denali Therapeutics. EV/EBITDA, changes, %
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -3.09 | -2.96 | -3.18 | -3.90 | -5.01 | -5.16 | |
| Changes by years, y/y, % | -72% | -53% | -62% | -28% | +62% | |||
| Changes by quarters, q/q, % | -43% | -4% | +7% | +22% | +29% | |||
